| Literature DB >> 29204221 |
Mehdi Abbasi1,2, Majid BaseriSalehi1, Nima Bahador1, Morovat Taherikalani3.
Abstract
AIMS &Entities:
Keywords: Antibiotic; Ilam; Iran; MRSA; PFGE; SCCmec typing
Year: 2017 PMID: 29204221 PMCID: PMC5688384 DOI: 10.2174/1874285801711010211
Source DB: PubMed Journal: Open Microbiol J ISSN: 1874-2858
The antimicrobial susceptibility patterns of S. aureus isolates.
| Antibiotic | MRSA | MSSA | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| No. (%) | No. (%) | No. (%) | |||||||
| R I S | R I S | R I S | |||||||
| Gentamicin | 30(83.3) | 1(2.7) | 5(13.8) | 10(19.2) | 5(9.6) | 37(71.1) | 40(45) | 6(6.8) | 42(47.7) |
| Erythromycin | 30(83.3) | 0(0) | 6(16.6) | 17(32.6) | 2(3.8) | 33(63.4) | 47(53) | 2(2.2) | 39(44.3) |
| Doxycycline | 12(33.3) | 6(16.6) | 18(50) | 4(7.6) | 7(13.4) | 41(78.8) | 16(18) | 13(14.7) | 59(67) |
| Minocycline | 5(13.8%) | 6(16.6%) | 25(69.4%) | 1(1.9%) | 2(3.8) | 49(94.2) | 6(6.8) | 8(9) | 74(84) |
| Ciprofloxacin | 11(30.5) | 6(16.6) | 19(52.7) | 1(1.9) | 2(3.8) | 49(94.2) | 12(13.3) | 8(9) | 68(77) |
| Clindamycin | 19(52.7) | 3(8.3) | 14(38.8) | 7(13.4) | 3(5.7) | 42(80.7) | 26(29.5) | 6(6.8) | 56(63) |
| Trimethoprim Sulfamethoxazole | 14(38.8) | 0(0) | 22(61.1) | 3(5.7) | 0(0) | 49(94.2) | 17(19) | 0(0) | 71(80) |
| Rifampin | 13(36.1) | 0(0) | 23(63.8) | 0(0) | 0(0) | 52(100) | 13(14.7) | 0(0) | 75(85) |
| Quinupristindalfopristin | 1(2.7) | 0(0) | 35(97.2) | 0(0) | 1(1.9) | 51(98) | 1(1.1) | 1(1.1) | 86(97) |
| Linezolid | 1(2.7) | 0(0) | 35(97.2) | 3(5.7) | 0(0) | 49(94.2) | 4(4.5) | 0(0) | 84(95) |
R=Resistant, S=Sensitive, I=Intermediate
Distribution of resistant gene among erythromycin and clindamycin resistant S. aureus isolates.
| Genes | Erythromycin | Clindamycin | Erythromycin & Clindamycin | |||
|---|---|---|---|---|---|---|
| MRSA | MSSA | MRSA | MSSA | MRSA | MSSA | |
| No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | |
| 5(16.6) | 4(23.5) | 2(22.2) | 2(66.6) | 2(28.5) | 1(25) | |
| 4(13.3) | 1(5.8) | 2(22.2) | 1(16.6) | 1(4.2) | 1(25) | |
| 0(0) | 3(17.6) | 0(0) | 1(16.6) | 0(0) | 1(25) | |
| 0(0) | 2(11.7) | 0(0) | 1(16.6) | 1(0) | 0(2.1) | |
| 1(3.3) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | |
| 7(23.3) | 10(58.8) | 3(33.3) | 1(16.6) | 2(8.5) | 1(25) | |
| 3(10) | 0(0) | 2(22.2) | 0(0) | 1(4.2) | 0(0) | |
| 0(0) | 2(11.7) | 0(0) | 1(16.6) | 0(0) | 0(0) | |
| 20(66.6) | 13(76.4) | 9(100) | 7(100) | 7(100) | 4(100) | |
Distribution of virulence genes among MRSA and MSSA isolate
| Gene | MRSA | MSSA | Total |
|---|---|---|---|
| No. (%) | No. (%) | No. (%) | |
| 0 (0) | 1(1.9) | 1 (1.1) | |
| 0 (0) | 0(0) | 0 (0) | |
| 4(8.3) | 9(17.3) | 13 (14.7) | |
| 0 (0) | 0(0) | 0 (0) | |
| 9(25) | 21(40.3) | 30 (34.1) | |
| 0 (0) | 0(0) | 0 (0) | |
| 0 (0) | 0(0) | 0 (0) | |
| 0 (0) | 0(0) | 0 (0) | |
| 3(8.3) | 6(11.5) | 9 (10.2) | |
| 8(22.2) | 1(1.9) | 9 (10.2) | |
| 1(2.7) | 5(9.6) | 6 (6.8) | |
| 11(30.5) | 19(34.6) | 30 (34.1) |
Distribution of virulence genes among MRSA and MSSA isolate.
| Gene | MRSA | MSSA | Total |
|---|---|---|---|
| No. (%) | No. (%) | No. (%) | |
| 0 (0) | 1(1.9) | 1 (1.1) | |
| 0 (0) | 0(0) | 0 (0) | |
| 4(8.3) | 9(17.3) | 13 (14.7) | |
| 0 (0) | 0(0) | 0 (0) | |
| 9(25) | 21(40.3) | 30 (34.1) | |
| 0 (0) | 0(0) | 0 (0) | |
| 0 (0) | 0(0) | 0 (0) | |
| 0 (0) | 0(0) | 0 (0) | |
| 3(8.3) | 6(11.5) | 9 (10.2) | |
| 8(22.2) | 1(1.9) | 9 (10.2) | |
| 1(2.7) | 5(9.6) | 6 (6.8) | |
| 11(30.5) | 19(34.6) | 30 (34.1) |
Distribution of major SCCmec and pulsotypes among MRSA isolates according to antibiotic resistant phenotype.
| Antibiotic Resistant Phenotypes | No. (%) | Major SCCmec Types No. (%) | Major PulsotypesNo. (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | N | 1 | 6 | 12 | 15 | 31 | ||
| 36(100) | 9(25) | 10(27) | 7(19.4) | 6(16.6) | 4(11.1) | 4(12.1) | 6(18.1) | 1(3) | 6(18.1) | 2(6) | |
| Gentamicin | 30(83.3) | 9(25) | 7(19.4) | 7(19.4) | 5(13.8) | 2(5.5) | 3(9) | 6(18.1) | 1(3) | 5(15.1) | 1(3) |
| Erythromycin | 30(83.3) | 8(22.2) | 7(19.4) | 6(16.6) | 5(13.8) | 4(11.1) | 3(9) | 6(18.1) | 0(0) | 5(15.1) | 0(0) |
| Doxycycline | 12(33.3) | 3(8.3) | 2(5.5) | 4(11.1) | 1(2.7) | 2(5.5) | 1(3) | 2(6) | 0(0) | 3(9) | 0(0) |
| Minocycline | 5(13.8) | 3(8.3) | 1(2.7) | 1(2.7) | 0(0) | 0(0) | 1(3) | 2(6) | 0(0) | 2(6) | 0(0) |
| Ciprofloxacin | 11(30.5) | 5(13.8) | 3(8.3) | 2(5.5) | 1(2.7) | 0(0) | 3(9) | 2(6) | 1(3) | 1(3) | 0(0) |
| Clindamycin | 19(52.7) | 5(13.8) | 3(8.3) | 6(16.6) | 3(8.3) | 2(5.5) | 3(9) | 3(9) | 1(3) | 2(6) | 1(3) |
| Trimethoprim | 14(38.8) | 3(8.3) | 2(5.5) | 3(8.3) | 4(11.1) | 2(5.5) | 2(6) | 2(6) | 1(3) | 2(6) | 1(3) |
| Rifampin | 13(36.1) | 6(16.6) | 2(5.5) | 4(11.1) | 0(0) | 1(2.7) | 1(3) | 2(6) | 1(3) | 1(3) | 1(3) |
| Quinupristindalfopristin | 1(2.7) | 0(0) | 0() | 0(0) | 0(0) | 1(2.7) | 0(0) | 0(0) | 0(0) | 1(3) | 0(0) |
| Linezolid | 1(2.7) | 0(0) | 0() | 1(2.7) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 1(3) |
Phenotypic and genotypic features of 36 MRSA isolates in this study.
| Sample No |
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 55 | Women, internal | Bed | FOX, GM,E, D,MI, CIP, RA | 6 | I | ||
| 62 | Women, surgery | Computer | FOX, GM,E, CIP,DA, TMP, RA | 6 | I | ||
| 77 | NICU | Air | FOX, GM,E | 6 | II | ||
| 93 | Men, internal | Tralee | FOX, GM,E, DA, TMP | 6 | IV | ||
| 100 | ICU | Sink | FOX, GM,E, DA | 6 | I | ||
| 118 | CCU | Bed | FOX, GM,E,MI, CIP, DA, RA | 6 | III | ||
| 31 | CCU | Station | FOX, GM,E, D,MI, RA | 15 | II | ||
| 34 | Women, surgery | Mobile staff | FOX | 15 | N | ||
| 54 | ICU | IPhone | FOX, GM,E, D, CIP,DA, TMP | 15 | III | ||
| 104 | Men, Post CCU | Air | FOX, GM,E,MI | 15 | I | ||
| 111 | Women, internal | Station | FOX, GM,E | 15 | IV | ||
| 14 | CCU | Ventilator | FOX, GM,E, CIP, DA, RA | 1 | I | ||
| 36 | CCU | Air | FOX, GM | 1 | III | ||
| 47 | CCU | Ventilator | FOX,E, CIP, DA, TMP | 1 | N | ||
| 99 | NICU | Incubator | FOX, GM,E,MI, CIP, DA, TMP | 1 | II | ||
| 25 | CCU | Staff=Men | FOX, GM,E, CIP, DA, RA | 24 | N | ||
| 27 | CCU | Monitor | FOX, | 24 | I | ||
| 35 | CCU | Air | FOX, E, DA, RA | 24 | II | ||
| 53 | NICU | Station | FOX | 31 | II | ||
| 102 | Emergency department | Ventilator | FOX, GM,E, DA, TMP, RA, LNZ | 31 | III | ||
| 24 | CCU | Staff=Men | FOX, GM,E, CIP, DA, RA | 26 | II | ||
| 75 | Operating room | Medicine cabinet | FOX, GM,E | 26 | I | ||
| 4 | CCU | Staff=Men | FOX, GM,E | 28 | II | ||
| 20 | Men, Post CCU | Staff=Men | FOX, GM, | 10 | IV | ||
| 28 | NICU | Medicine cabinet | FOX, GM,E, CIP, DA, RA | 8 | II | ||
| 29 | Women, surgery | Bed | FOX, GM,E, D, TMP | 18 | N | ||
| 30 | NICU | Station | FOX, GM,E, D, TMP | 20 | I | ||
| 43 | ICU | patient=BC | FOX, GM,E, DA, RA | 9 | IV | ||
| 43 | ICU | patient=BC | FOX, GM,E, DA, RA | 9 | IV | ||
| 56 | Women, internal | Refrigerator | FOX, GM,E,DA, TMP | 11 | IV | ||
| 68 | Men, internal | Refrigerator | FOX, GM | 12 | IV | ||
| 72 | NICU | Station | FOX, GM,E, DA | 27 | III | ||
| 83 | Men, Post CCU | Air | FOX,E, TMP | 5 | II | ||
| 90 | ICU | Cover records | FOX, GM,E, D, CIP, DA, RA | 22 | III | ||
| 91 | Women Surgery | Floor | FOX, GM,E, CIP, DA, TMP, RA | 3 | I | ||
| 96 | CCU | Tralee | FOX, GM,E, D, TMP | 23 | III | ||